An appeals court in New York has for the second time dismissed an antitrust lawsuit against a Chinese exporter of vitamin C. The judges ruled that the North China Pharmaceutical Group Corp (NCPC) could not be held liable for a violation of US antitrust law due to Chinese export regulations. The set of rules in the People’s Republic made it impossible for the company to meet conditions to export to the United States. The court dismissed the case accordingly. US manufacturers had sued for damages amounting to 147 million US dollars.
Continue reading now
… and get free access to this Professional Briefing for a month.
Are you already a guest at the China.Table? Log in now